Spotlight Series on Hepatitis C


State Medicaid Programs Ease Illegal Restrictions on Hepatitis C Medications, but More Progress Needed

November 16, 2016


More Transparency

More Transparency

When Greenwald first set out to survey Medicaid restrictions in 2014, he ran into a fundamental problem. Seventeen states did not make their criteria public, meaning that Greenwald and other advocates had little way of knowing which policies were in place except by word of mouth from patients. By 2016, only seven states did not have publicly available policies, Greenwald explained during his presentation. The numbers have improved: 73% of states had available information in 2014, compared with 82% in 2016. Despite the progress, Greenwald and Clary called on all state Medicaid directors to immediately release hepatitis C treatment access criteria.

Credit: LizaLutik for iStock via Thinkstock.

This article was provided by It is a part of the publication The Liver Meeting.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.